Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Clinical endocrinology - 1 Aug 2026

Tienforti Daniele, Puocci Gennaro, Venditti Claudia, Gizzi Valentina, Pisanò Carlo, Cocci Elisa, Perfetto Elisabetta, D'Alessandro Francesco, Spagnolo Luca, Baroni Marco Giorgio, Barbonetti Arcangelo

Abstract excerpt

OBJECTIVE: To evaluate the effect of inositol supplementation on biochemical hyperandrogenism in women with polycystic ovary syndrome (PCOS) and to explore whether metabolic phenotype modifies the endocrine response. DESIGN: Systematic review and meta-analysis of randomized controlled trials conducted in accordance with PRISMA guidelines. PATIENTS: Women diagnosed with PCOS according to established criteria (NIH,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Supplements
Share to Hyperandrogenism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inositol

Share to Insulin Resistance

Share to Polycystic Ovary Syndrome

Share to Randomized Controlled Trials as Topic

Share to Sex Hormone-Binding Globulin

Share to Testosterone

Source

Open in PubMed Open full text

Identifiers

PMID: 41947399
DOI: 10.1111/cen.70140
PMCID: PMC13326987

Genes

SHBG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.PMID 41947399Read ↗

Myo-inositol versus Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Anthropometric, Endocrine, Metabolic, and Reproductive OutcomesSemantic proximity Read ↗

Tailoring treatment for PCOS phenotypes.Semantic proximity Read ↗

Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial.Semantic proximity Read ↗

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.Semantic proximity Read ↗

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.Semantic proximity Read ↗

Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS.Semantic proximity Read ↗

Clinical Phenotypes of PCOS: a Cross-Sectional Study.Semantic proximity Read ↗

The effect of Myo-Inositol supplement on molecular regulation of folliculogenesis, steroidogenesis, and assisted reproductive technique outcomes in patients with polycystic ovarian syndromeSemantic proximity Read ↗

Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome.Semantic proximity Read ↗

The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.Semantic proximity Read ↗

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.Semantic proximity Read ↗

Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.